Back to Forecasting
PCTActive

Will PCT report FY2026 revenue exceeding $30M?

Resolves March 31, 2027(371d)
IG: 0.80

Current Prediction

18%
Likely No
Model Agreement96%
Predictions9 runs
Last UpdatedMarch 22, 2026

Why This Question Matters

Revenue trajectory directly tests whether the FRAGILE revenue durability assessment is too pessimistic or accurate. $30M for FY2026 would represent ~3.6x growth from $8.4M, requiring meaningful Ironton ramp success. Achieving this would narrow the narrative-reality gap and suggest the technology scales. Falling short would confirm the single-facility risk and raise questions about whether $8.4M was an anomaly rather than a foundation.

REVENUE_DURABILITYNARRATIVE_REALITY_GAPEXPECTATIONS_PRICED

Prediction Distribution

0%25%50%75%100%
opus
sonnet
haiku
Range: 15%22%Aggregate: 18%
Individual Predictions(9 runs)
opusRun 1
18%

PCT reported $8.4M in FY2025, its first year of revenue. $30M for FY2026 requires 3.6x growth, implying ~$7.5M per quarter. This is nearly the entire FY2025 revenue every quarter. Ironton required a turnaround that will consume part of the production calendar. The committee assessed UNIT_ECONOMICS as BROKEN and REVENUE_DURABILITY as FRAGILE. Single-facility risk means any disruption eliminates all revenue. Customer base is early-stage. Even assuming a successful turnaround, ramping from ~$2M/quarter average to $7.5M/quarter consistently is extremely demanding for a facility that hasn't demonstrated stable production.

3.6x growth requires $7.5M/quarter from $2.1M averageTurnaround consumes production calendar in early 2026Single facility means zero redundancy during ramp
opusRun 2
15%

The math is demanding. FY2025 averaged ~$2.1M/quarter. Even if the turnaround doubles throughput (optimistic), we get ~$4.2M/quarter average for FY2026, totaling ~$16.8M — well short of $30M. To reach $30M, throughput would need to approximately quadruple and sustain that level for most of the year. Chemical processing facilities rarely achieve 4x throughput improvement in a single year, especially when starting from initial production with demonstrated scaling issues. The BROKEN unit economics assessment reinforces this skepticism.

Even doubling throughput yields ~$16.8M — half the target4x throughput improvement required is historically rareBROKEN unit economics suggests fundamental barriers to scaling
opusRun 3
20%

I'll consider the bull case: if the turnaround is highly successful and addresses the primary bottleneck, Ironton could potentially reach a much higher utilization rate in H2 2026. Chemical processing economics are nonlinear — small changes in utilization can produce large changes in output. If Ironton was running at 10-15% utilization, a turnaround that brings it to 40-50% could produce $5-8M/quarter. But this requires the turnaround solving the core issue (not just patching), immediate ramp after downtime, and stable production for 3+ quarters. The conjunction of these favorable outcomes is unlikely given the analysis findings.

Bull case: turnaround solves core bottleneck, utilization jumps to 40-50%Nonlinear chemical processing economics could amplify improvementConjunction of favorable outcomes required makes this unlikely
sonnetRun 1
22%

FY2025 was the first year of revenue, and year-2 chemical processing ramps can be significant. The turnaround is designed to address the specific throughput constraints. If successful, H2 2026 could see meaningfully higher production. The customer pipeline exists (management says only small percentage needed to fill capacity). Regulatory mandates create pull demand. However, $30M requires approximately $7.5M/quarter average, which is a large jump from $2.1M. The most likely scenario is meaningful improvement that falls short of $30M — perhaps $15-20M for FY2026.

Year-2 ramps can be significant in chemical processingCustomer demand exists per managementMost likely outcome is improvement falling short of $30M
sonnetRun 2
17%

The $30M threshold is specifically demanding. Even if we assume Q1 2026 is a turnaround quarter (low revenue), Q2-Q4 would need to average $9-10M each to compensate. That's essentially 4-5x the FY2025 quarterly run rate, sustained for three consecutive quarters. In a facility that has never demonstrated stable production at any level, this is extremely optimistic. The FRAGILE revenue assessment and single-facility concentration amplify the risk. Revenue of $15-20M is more plausible but $30M requires near-perfect execution.

If Q1 is turnaround quarter, Q2-Q4 must average $9-10M each4-5x quarterly improvement sustained for 3 quartersNear-perfect execution required at untested levels
sonnetRun 3
20%

I'll assign the base case as ~$15-18M FY2026 revenue (a significant improvement but short of $30M). The right tail that reaches $30M requires: (1) turnaround completed by Q1 end, (2) immediate ramp to high utilization, (3) no new disruptions, (4) customer demand materializing. Each individually is plausible but the conjunction is demanding. I estimate ~20% probability that everything aligns for the $30M threshold, with the base case being meaningful improvement that falls short.

Base case ~$15-18M FY2026 is significant improvement but shortRight tail to $30M requires four favorable conditions simultaneouslyEach condition plausible but conjunction demanding
haikuRun 1
15%

3.6x growth from $8.4M base. Single facility that needed first-year turnaround. No demonstrated stable production. $30M requires near-perfect execution for the full year. Very demanding target given BROKEN unit economics and FRAGILE revenue.

3.6x growth from unstable production baseSingle facility with turnaround disruptionBROKEN unit economics and FRAGILE revenue
haikuRun 2
20%

Year-2 ramps in chemical processing can be significant. If turnaround solves the core issue, revenue could accelerate materially. But $30M is 3.6x growth — a very high bar. Most likely revenue is $12-18M range.

Year-2 ramp potentialTurnaround could unlock improvementBut 3.6x is a very high bar
haikuRun 3
17%

The turnaround takes production offline, then must ramp back up, then maintain at higher levels. Full year includes downtime quarter. $30M from $8.4M with a facility that has never demonstrated stable production at any level is extremely ambitious.

Turnaround creates downtime that reduces available production daysNo history of stable production at any levelExtremely ambitious target

Resolution Criteria

Resolves YES if PCT's 10-K for FY2026 (filed Q1 2027) reports total revenue of $30M or more. Resolves NO if total revenue is below $30M.

Resolution Source

PCT 10-K for fiscal year ending December 31, 2026

Source Trigger

Revenue trajectory — revenue durability depends on Ironton ramp and virgin PP premium

gravy-gaugeREVENUE_DURABILITYHIGH
View PCT Analysis

Full multi-lens equity analysis